Se connecter S'abonner en ligne
  • Infos sociétés
  • Infos OPCVM
  • Alertes e-mail
  • Notre offre
 Langues  Par thème  Par secteur d'activité  Par pays
HeartBeat.bio AG    
[02/11/2023]

HeartBeat.bio AG : EQS-News: HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery

EQSNews: HeartBeat.bio AG / Key words: Financing HeartBeat.bio raises € 4.5 million in PreSeries A financing to drive development of organoid screening platform for cardiac drug discovery 02.11.2023 / 11:00 CET/CEST The issuer is solely responsible for the content of this announcement. Hear... Lire le communiqué
 
HeartBeat.bio AG    
[05/10/2022]

HeartBeat.bio AG : EQS-News: HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases

EQSNews: HeartBeat.bio AG / Key words: Agreement HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases 05.10.2022 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. HeartBeat.bio c... Lire le communiqué
 
HeartBeat.bio AG    
[12/09/2022]

HeartBeat.bio AG : HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery

DGAPNews: HeartBeat.bio AG / Key words: Alliance HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for highthroughput screening in drug discovery 12.09.2022 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. HeartBeat.bio and Molec... Lire le communiqué
 


Vidéos
Gestionnaires,
Emetteurs,
Ma sélection
Les communiqués les plus lus de HeartBe...